Pfizer Just Locked Next Growth Path: What Investors Should Know
Pfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
An easy reference to world market indices names, with notes on regional coverage and how to recognize key benchmarks in discussions.
28,329 articlesPfizer has reset its growth trajectory with big bets on Seagen and a future GLP-1 drug. This analysis breaks down wha...
The Senate Banking Committee moved the CLARITY Act forward, setting the stage for a broader battle over crypto regula...
Markets cooled early May 2026 as inflation data rolled in, but investors pressed ahead with digital planning. This re...
As 2026 unfolds, the Ethereum Foundation confronts a notable wave of exits. An insider explains wave 2026 as a planne...
A national review identifies about 82,000 2023 FHA mortgages with small subordinate liens, totaling roughly $880 mill...
Missed inquiries are quietly eroding real estate commissions as buyers and sellers move quickly to rivals. A new stud...
UBS contends that the math behind DeSantis' flagship property tax relief may not deliver the promised relief. Florida...
Weibo's Q1 2026 earnings transcript reveals a steady growth path with ad-driven strength and improving non-ad monetiz...
A 70-member roster of marketers across mortgage, real estate and housing tech is being honored for driving growth and...
As markets wobble, investors eye tax-efficient income. This report explains how a Roth IRA can magnify monthly divide...
A new retirement study finds a majority of Americans believe a 401(K) balance is enough for retirement, while nearly ...
A longtime bitcoin advocate says MicroStrategy is a leveraged proxy for Bitcoin, and could trade at $1,000 per share ...